HedgeFund.net: Public news from HedgeNews
|
|
|
|
|
|
|
| Click below for information on membership options |
|
|
Third Point Out of PDL Following Board Bid
by Christopher Glynn ,Senior Reporter, November 13, 2007
Third Point liquidated its stake in PDL BioPharma as a result of being denied a seat on the board of the California company.
Third Point sold its remaining stock in PDL, according to a filing. A month ago, Third Point revealed it had lowered its stake in PDL to 5.1% from 9.7% after being rebuffed.
In a letter, Third Point Chief Executive Officer Daniel Loeb said he felt “encouraged” with the decision to sell the company, but said he wanted greater involvement in the process. The biopharmaceutical outfit had been plagued with poor performance as well as the troubled tenure of its chief executive officer, prompting its sale last month.
Despite being denied a seat on the PDL board, Loeb, a manager noted for his aggressive shareholder activism, spearheaded a successful campaign for the ouster of former PDL Chief Executive Officer Mark McDade.
McDade resigned in August amid doubt about his leadership. Loeb had lambasted the erstwhile CEO for what he characterized as “pathological selfishness and poor business judgment.”
McDade said he would remain onboard at the company until the end of the year. Chairman Patrick Gage has meanwhile assumed the role of CEO.
Despite the departure of Third Point, PDL is still hounded with hedge fund-based shareholder activism.
Highland Capital Management, allied with Third Point in its proxy fight against PDL, has a 5.2% stake in the company.
Like Third Point, Dallas-headquartered Highland had pressured PDL to sell itself. Highland had also clamored for the ouster of McDade and is pushing for the resignation of Gage.
In addition to Highland, $14 billion Connecticut-based hedge fund firm SAC Capital is a passive owner.
|
|
 |
|
|
|
|
| |
|
|
| |
| |
|
Disclaimer: An affiliated broker-dealer of HedgeFund.net is compensated for providing
capital introduction services to hedge funds and hedge fund managers, which may
include one or more hedge funds mentioned in this article. Hedge funds and/or hedge
fund managers mentioned in this article also may compensate HedgeFund.net for services
provided to them by HedgeFund.net
|
|
|
|
|
|
|
|
NEITHER CHANNEL CAPITAL GROUP INC.("CCG"),ITS AFFILIATES,OR CCG'S OR ITS AFFILIATES RESPECTIVE OFFICERS,DIRECTORS,AGENTS,MEMBERS,SHAREHOLDERS AND EMPLOYEES (EACH A "CCG PARTY" AND COLLECTIVELY THE "CCG PARTIES")RECOMMENDS OR SOLICITS ANY INVESTMENT BY USERS OF THIS WEB SITE,THE MATERIAL CONTAINED HEREIN IS BASED UPON INFORMATION PROVIDED BY HEDGE FUND MANAGERS AND OTHER SOURCES. THE CCG PARTIES HAVE NOT INDEPENDENTLY VERIFIED SUCH INFORMATION,DO NOT REPRESENT IT AS ACCURATE ,TRUE OR COMPLETE, MAKE NO WARRENTY, EXPRESS OR IMPLIED REGARDING IT AND SHALL NOT BE LIABLE FOR ANY LOSSED,DAMAGES,COSTS, OR EXPENSES RELATING TO ITS ADEQUANCY ,ACCURACY ,TRUTH ,COMPLETENESS, OR USE, REGISTERED USERS SHOULD NOT RELY UPON DATA TO MAKE AN INVESTMENT DECISION ,AND SHOULD NOT THAT PAST PERFORMANCE IS NOT AN INDICATION OF FUTURE.
|
|
|
|